The following Masonic Cancer Center members are the Principal Investigators on projects that were awarded National Cancer Institute (NCI) Research Grants in the latest grant cycle.
Helen Parsons, PhD, MPH, was named the 2020 Order of the Eastern Star Scholar, an honor recognizing her commitment to the Masonic Cancer Center and to the Order’s extraordinary commitment to supporting the development of novel therapies and new treatments in the quest to cure cancer.
Dr. Parsons, an Associate Professor in the University of Minnesota School of Public Health, focuses much of her research on cancer survivorship and public policy around health care.
A number of Masonic Cancer Center members recently received promotions in their home base colleges.
College of Biological Sciences
Biochemistry, Molecular Biology and Biophysics
Yue Chen, PhD, promoted to Associate Professor with tenure
Aaron Goldstrohm, PhD, promoted to Full Professor
Michael Smanski, PhD, promoted to Associate Professor with tenure
Three important pieces of health-related legislation that were endorsed and supported by the Masonic Cancer Center were passed by the Minnesota House and Senate before the end of the current session, with one of them being signed into law by Minnesota Governor Tim Walz.
Author: Kelly Glynn, Media Relations Coordinator | MAY 14, 2020
MINNEAPOLIS, MN- May 14, 2020 – In a vertical climb to avoid collision with a towering mountain, a plane ejects cargo to gain altitude. Investigators at the University of Minnesota showed that cancer cells perform similar feats in escaping the killing effects of radiation. Their work was published in the May issue of the journal, EBiomedicine.
6th director comes from Georgetown University
Dr. Robert Clarke of Georgetown University in Washington, D.C., has been named the next executive director of The Hormel Institute, University of Minnesota.
New research sheds light on metastatic cancer in the liver
AUSTIN, Minn. – May 4, 2020 – Dr.Ningling Kang, head of the Tumor Microenvironment and Metastasis lab at The Hormel Institute UMN, published a discovery describing how a particular protein, diaphanous homolog 1 (Diaph1), turns normal liver cells into cancer-promoting cells.